MedPath

The utility of pedometers in improving mobility outcomes in inpatient rehabilitation - pilot randomised control trial (RCT)

Not Applicable
Completed
Conditions
reduced mobility
Physical Medicine / Rehabilitation - Other physical medicine / rehabilitation
Registration Number
ACTRN12616001161415
Lead Sponsor
Dr Chris Barr
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
78
Inclusion Criteria

Eligible participants will be adults admitted to an inpatient rehabilitation ward with reduced mobility (relative to their premorbid mobility) with a clinician-assessed capacity for improvement in mobility. They will be eligible once they can walk a minimum of 3 metres on the ward, with or without the assistance of one person, with or without a walking aid.

Exclusion Criteria

Exclusion criteria will be: insufficient English language skills to participate in rehabilitation and no available interpreter; severe receptive aphasia or inability to communicate; a medical condition precluding exercise (unstable cardiac disease, uncontrolled hypertension, uncontrolled metabolic diseases, large abdominal aortic aneurysm or a weight-bearing restriction such as non or touch weight bearing); not admitted under rehabilitation i.e. nursing home type; expected discharge date less than one week after recruitment to the study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
mobility measured by De Morton Mobility Index (DEMMI)[All participants will undergo two measurements sessions: one on entry into the study (baseline assessment), and one prior to discharge of rehabilitation (pre discharge), by a physiotherapist blinded to group allocation. Baseline assessments will be completed prior to randomization.]
Secondary Outcome Measures
NameTimeMethod
adapted pedometer satisfaction scale using 5 point Likert scales measuring level of helpfulness and enjoyment.[prior to discharge from rehabilitation (pre discharge)];All participants will have their activity monitored for the first week they are enrolled on the study using accelerometer (ActivPal – PAL technologies, Glasgow, United Kingdom) which will measure time upright and steps taken.[From baseline assessment for the first week];gait speed assessed using the 10 metre walk test (10MWT) [All participants will undergo two measurements sessions: one on entry into the study (baseline assessment), and one prior to discharge of rehabilitation (pre discharge), by a physiotherapist blinded to group allocation. Baseline assessments will be completed prior to randomization.];Functional independence measured by functional independence measure (FIM) [On admission, on recruitment to the study, and on discharge from the ward];steps taken measured by pedometer[assessed daily from baseline to pre discharge assessment]
© Copyright 2025. All Rights Reserved by MedPath